SB-0832, As Passed Senate, June 9, 2004                                     

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                              SUBSTITUTE FOR                                    

                                                                                

                           SENATE BILL NO. 832                                  

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                 A bill to amend 1939 PA 280, entitled                                             

                                                                                

    "The social welfare act,"                                                   

                                                                                

    (MCL 400.1 to 400.119b) by adding section 109h.                             

                                                                                

                THE PEOPLE OF THE STATE OF MICHIGAN ENACT:                      

                                                                                

1       Sec. 109h.  (1) If the department of community health                       

                                                                                

2   develops a prior authorization process for prescription drugs as            

                                                                                

3   part of the pharmaceutical services offered under the medical               

                                                                                

4   assistance program administered under this act, it shall not                

                                                                                

5   require prior authorization for the following single source brand           

                                                                                

6   name, multiple source brand name or its generic equivalent, or              

                                                                                

7   other prescription drugs:                                                   

                                                                                

8       (a) A prescription drug that is classified as an antianxiety,               

                                                                                

9   anticonvulsant, antidepressant, or antipsychotic central nervous            

                                                                                

10  system drug in a generally accepted standard medical reference.             

                                                                                

11      (b) A prescription drug that is cross-indicated for a                       

                                                                                


                                                                                

1   central nervous system drug exempted under subdivision (a) as               

                                                                                

2   documented in a generally accepted standard medical reference.              

                                                                                

3       (c) Unless the prescription drug is a controlled substance or               

                                                                                

4   the prescription drug is being prescribed to treat a condition              

                                                                                

5   that is excluded from coverage under this act, a prescription               

                                                                                

6   drug that is recognized in a generally accepted standard medical            

                                                                                

7   reference as effective in the treatment of conditions specified             

                                                                                

8   in the most recent diagnostic and statistical manual of mental              

                                                                                

9   disorders published by the American psychiatric association.                

                                                                                

10      (d) A prescription drug that is recognized in a generally                   

                                                                                

11  accepted standard medical reference for the treatment of and is             

                                                                                

12  being prescribed to a patient for the treatment of any of the               

                                                                                

13  following or its symptoms:                                                  

                                                                                

14                                                                               (i) Human immunodeficiency virus infections or the                                  

                                                                                

15  complications of the human immunodeficiency virus or acquired               

                                                                                

16  immunodeficiency syndrome.                                                  

                                                                                

17      (ii) Cancer.                                                                 

                                                                                

18      (iii) Organ replacement therapy.                                             

                                                                                

19      (iv) Epilepsy or seizure disorder.                                           

                                                                                

20      (2) As used in this section:                                                

                                                                                

21      (a) "Controlled substance" means that term as defined in                    

                                                                                

22  section 7104 of the public health code, 1978 PA 368, MCL                    

                                                                                

23  333.7104.                                                                   

                                                                                

24      (b) "Cross-indicated" means a drug which is used for a                      

                                                                                

25  purpose generally held to be reasonable, appropriate, and within            

                                                                                

26  community standards of practice even though the use is not                  


                                                                                

1   included in the federal food and drug administration's approved             

                                                                                

2   labeled indications for that drug.                                          

                                                                                

3       (c) "Department" means the department of community health.                  

                                                                                

4       (d) "Prescriber" means that term as defined in section 17708                

                                                                                

5   of the public health code, 1978 PA 368, MCL 333.17708.                      

                                                                                

6       (e) "Prescription" or "prescription drug" means that term as                

                                                                                

7   defined in section 17708 of the public health code, 1978 PA 368,            

                                                                                

8   MCL 333.17708.                                                              

                                                                                

9       (f) "Prior authorization" means a process implemented by the                

                                                                                

10  department of community health that conditions, delays, or denies           

                                                                                

11  the delivery of a particular pharmaceutical service upon                    

                                                                                

12  application of predetermined criteria by the department or the              

                                                                                

13  department's agent for that pharmaceutical service.  The process            

                                                                                

14  may require a prescriber to verify with the department or the               

                                                                                

15  department's agent that the proposed medical use of a                       

                                                                                

16  prescription drug being prescribed for a patient meets the                  

                                                                                

17  predetermined criteria for a prescription drug that is otherwise            

                                                                                

18  covered under this act or require a prescriber to obtain                    

                                                                                

19  authorization from the department or the department's agent                 

                                                                                

20  before prescribing or dispensing a prescription drug that is not            

                                                                                

21  included on a preferred drug list or that is subject to special             

                                                                                

22  access or reimbursement restrictions.